Ribavirin for Chronic Hepatitis C

  1. Adrian M. Di Bisceglie, MD; and
  2. Jay H. Hoofnagle, MD
  1. St. Louis University Health Sciences Center, St. Louis, MO 63104 National Institutes of Health, Bethesda, MD 20892

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they …

    This 100-word excerpt has been provided in the absence of an abstract.

    [Full Text of this Article]
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med October 15, 1996 vol. 125 no. 8 699
    1. » Excerpt
    2. Full Text
    3. Full Text (PDF)

    Rapid Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. December 15, 2009, 151 (12)
    1. Alert me to current issues